Bill Summary for H 464 (2017-2018)
Printer-friendly: Click to view
Summary date:
Bill Information:
| View NCGA Bill Details | 2017-2018 Session |
AN ACT REVISING THE SCHEDULE OF CONTROLLED SUBSTANCES TO ADD SYNTHETIC FENTANYLS, DESIGNER HALLUCINOGENICS, SYNTHETIC CANNABINOIDS, SYSTEM DEPRESSANTS, AND OTHER SUBSTANCES AND MAKING CONFORMING CHANGES; AND CREATING THE TASK FORCE ON SENTENCING REFORMS FOR OPIOID DRUG CONVICTIONS.Intro. by Horn, Murphy, Malone.
| View: All Summaries for Bill | Tracking: |
Bill summary
House committee substitute makes the following changes to the 2nd edition.
Amends GS 90-87 (Definitions). Amends definitions of isomer and narcotic drugs, and defines opioid.
Amends GS 90-89 (Schedule I controlled substances). Includes opioids within the description of opiates under subsection (1), and amends the description of alphacetylmethadol to exclude levo-alphacetylmethadol. Adds Phenazepam to the list of controlled systemic depressants. Amends the description of controlled stimulants structurally derived from 2-amino-1-phenyl-1-propane.
Amends GS 90-90 (Schedule II controlled substances). Includes opioids within the description of opiates.
Amends GS 90-92 (Schedule IV controlled substances). Moves Tramadol from the list of controlled depressants to the list of controlled narcotic drugs.
Amends GS 90-93 (Schedule V controlled substances). Adds two substances, Brivaracetam and Pregabalin, to the list of controlled anticonvulsants.
Makes technical changes.